The RECLAIM Study.
RecruitingNCT06450444Phase: NAStarted 2024-06-24
Summary
The purpose of this study is to evaluate the safety and performance, including clinical benefit, of the PRIMUS System for the treatment of Resistant Migraine.
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
84 Years
Locations
Genesis Research ServicesBroadmeadow, New South Wales, Australia
Resolve PainBuderim, Queensland, Australia
ZAS Antwerpen, Campus Sint-AugustinusWilrijk, Antwerpen, Belgium
Jessa HasseltHasselt, Limburg, Belgium
Private Practice Dr. SavaSaint-Nicolas, Liège, Belgium
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06450444